- Home
- IRMD
IRMD
iRadimed Corporation
as 07-26-2024 4:00pm EST
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Upcoming Earnings Alert:
Get ready for potential market movements as iRadimed Corporation IRMD prepares to release earnings report on 01 Aug 2024.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | WINTER SPRINGS |
| Market Cap: | 572.4M | IPO Year: | 2014 |
| Target Price: | $65.00 | AVG Volume (30 days): | 55.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.41 | EPS Growth: | 28.18 |
| 52 Week Low/High: | $36.12 - $50.85 | Next Earning Date: | 08-01-2024 |
| Revenue: | $67,685,331 | Revenue Growth: | 19.87% |
| Revenue Growth (this year): | 12.47% | Revenue Growth (next year): | 12.28% |
Stock Insider Trading Activity of iRadimed Corporation (IRMD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ALLEN MONTY K | IRMD | Director | Jun 3 '24 | Sell | $43.37 | 1,947 | $84,432.43 | 18,053 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 26 '23 | Sell | $46.00 | 5,000 | $230,000.00 | 167,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 26 '23 | Sell | $46.51 | 5,000 | $232,547.00 | 162,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 18 '23 | Sell | $44.08 | 5,000 | $220,402.50 | 177,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 18 '23 | Sell | $45.14 | 5,000 | $225,696.50 | 172,950 | SEC Form 4 |
| HAWKINS JAMES B | IRMD | Director | Dec 12 '23 | Sell | $43.40 | 468 | $20,308.86 | 39,348 | SEC Form 4 |
| HAWKINS JAMES B | IRMD | Director | Dec 12 '23 | Sell | $43.40 | 504 | $21,871.08 | 39,348 | SEC Form 4 |
| HAWKINS JAMES B | IRMD | Director | Dec 12 '23 | Sell | $42.80 | 5,000 | $213,988.50 | 39,348 | SEC Form 4 |
| HAWKINS JAMES B | IRMD | Director | Dec 12 '23 | Sell | $43.61 | 219 | $9,551.40 | 39,348 | SEC Form 4 |
| HAWKINS JAMES B | IRMD | Director | Dec 12 '23 | Sell | $44.58 | 4,277 | $190,687.05 | 39,348 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 11 '23 | Sell | $41.24 | 5,000 | $206,190.50 | 187,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 11 '23 | Sell | $42.82 | 5,000 | $214,113.00 | 182,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 4 '23 | Sell | $41.42 | 5,000 | $207,109.50 | 192,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Dec 4 '23 | Sell | $42.11 | 5,000 | $210,568.00 | 197,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 27 '23 | Sell | $41.80 | 5,000 | $209,006.00 | 207,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 27 '23 | Sell | $40.37 | 5,000 | $201,861.50 | 202,950 | SEC Form 4 |
| VUOTO ANTHONY | IRMD | Director | Nov 10 '23 | Sell | $39.91 | 818 | $32,644.66 | 16,375 | SEC Form 4 |
| VUOTO ANTHONY | IRMD | Director | Nov 10 '23 | Sell | $39.75 | 2,237 | $88,921.64 | 14,138 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 6 '23 | Sell | $42.91 | 5,000 | $214,535.50 | 237,950 | SEC Form 4 |
| Susi Roger E. | IRMD | CEO, PRESIDENT, CHAIRMAN | Nov 6 '23 | Sell | $41.34 | 5,000 | $206,711.00 | 232,950 | SEC Form 4 |
Latest iRadimed Corporation News
IRMD Breaking Stock News: Dive into IRMD Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
Simply Wall St.
a month ago
What Does IRADIMED CORPORATION's (NASDAQ:IRMD) Share Price Indicate?
Simply Wall St.
a month ago
Here's Why IRADIMED CORPORATION's (NASDAQ:IRMD) CEO May Deserve A Raise
MT Newswires
2 months ago
iRadimed to Begin Trading on the Nasdaq Global Market
GlobeNewswire
2 months ago
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Simply Wall St.
2 months ago
IRADIMED (NASDAQ:IRMD) Is Achieving High Returns On Its Capital
Insider Monkey
3 months ago
IRadimed Corporation (NASDAQ:IRMD) Q1 2024 Earnings Call Transcript
Simply Wall St.
3 months ago
IRADIMED CORPORATION Just Beat EPS By 6.7%: Here's What Analysts Think Will Happen Next
Compare IRMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRMD iRadimed Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.